Statement on Cochrane Airways funding

In August 2021 we learned that our National Institute for Health Research (NIHR) funding will cease in March 2023. We are grateful to have benefitted from many years of stable funding from NIHR for the Cochrane Airways editorial team, based at St George’s University of London, who support the production of Cochrane Airways Reviews. We are disappointed because the huge group of people who make up Cochrane Airways round the world will lose the group that is holding us all together while we produce the Cochrane Reviews that are so important for decision-makers.

Cochrane is in the process of developing a new model, and you can join in that discussion here.

We are not certain what the future holds, but we do know that we will not be employed to work on supporting and publishing Cochrane Airways Reviews after March 2023. We have developed a plan to fulfil our obligations to the funder and also to produce the best reviews that we can for the public in the time we have left.

We will be working on producing up to 20 high-priority reviews, and we will focus on the ones that are already in development. We will contact lead authors of these reviews soon.

We have also taken the decision that we will not register any new review titles to new author teams. We may make a small number of exceptions for author teams with a proven track record who propose to complete reviews, and who can demonstrate they have adequate support and a sensible timeline for delivery.